Argos Therapeutics (FRA:77AA) Long-Term Debt : €10.25 Mil (As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Long-Term Debt?

Argos Therapeutics's Long-Term Debt for the quarter that ended in Sep. 2018 was €10.25 Mil.

Argos Therapeutics's quarterly Long-Term Debt increased from Mar. 2018 (€9.75 Mil) to Jun. 2018 (€10.38 Mil) but then declined from Jun. 2018 (€10.38 Mil) to Sep. 2018 (€10.25 Mil).

Argos Therapeutics's annual Long-Term Debt declined from Dec. 2015 (€28.21 Mil) to Dec. 2016 (€17.70 Mil) and declined from Dec. 2016 (€17.70 Mil) to Dec. 2017 (€10.25 Mil).

Argos Therapeutics Long-Term Debt Historical Data

The historical data trend for Argos Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Long-Term Debt Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Long-Term Debt

Get a 7-Day Free Trial

5.12

16.06

28.21

17.70

10.25

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Long-Term Debt	Get a 7-Day Free Trial															13.22	10.25	9.75	10.38	10.25

Argos Therapeutics (FRA:77AA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Argos Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Argos Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines